These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 1148393

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/ paroxysmal nocturnal hemoglobinuria during evolution to clonal disease.
    Mortazavi Y, Tooze JA, Gordon-Smith EC, Rutherford TR.
    Blood; 2000 Jan 15; 95(2):646-50. PubMed ID: 10627475
    [Abstract] [Full Text] [Related]

  • 11. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
    Medof ME, Gottlieb A, Kinoshita T, Hall S, Silber R, Nussenzweig V, Rosse WF.
    J Clin Invest; 1987 Jul 15; 80(1):165-74. PubMed ID: 2439544
    [Abstract] [Full Text] [Related]

  • 12. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Forés R, Alcocer M, Cabrera R, Sanjuán I, Briz M, Lago C, Fernández MN.
    Sangre (Barc); 1999 Jun 15; 44(3):199-203. PubMed ID: 10481581
    [Abstract] [Full Text] [Related]

  • 13. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia.
    Hugel B, Socié G, Vu T, Toti F, Gluckman E, Freyssinet JM, Scrobohaci ML.
    Blood; 1999 May 15; 93(10):3451-6. PubMed ID: 10233897
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Expression of three kinds of GPI-anchor proteins in paroxysmal nocturnal hemoglobinuria, aplastic anemia and myelodysplastic syndromes patients and their clinical implications].
    Dong XY, Xu CG, Sun GR, Zhang T, Peng J.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Apr 15; 25(4):198-201. PubMed ID: 15182554
    [Abstract] [Full Text] [Related]

  • 18. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Kinoshita T, Inoue N.
    Int J Hematol; 2002 Feb 15; 75(2):117-22. PubMed ID: 11939256
    [Abstract] [Full Text] [Related]

  • 19. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH, Rosenfeld SI, Jenkins DE, Thiem PA, Leddy JP.
    J Clin Invest; 1979 Aug 15; 64(2):428-33. PubMed ID: 457861
    [Abstract] [Full Text] [Related]

  • 20. Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells.
    Rouault TA, Rosse WF, Bell S, Shelburne J.
    Blood; 1978 Feb 15; 51(2):325-30. PubMed ID: 620087
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.